Therapeutic Nanomaterials in NAFLD: Current Advances and Potential Applications in Patients with Concurrent HBV Infection

Guixin Li,1,* Zheng Dai,2,3,* Jinghui Guo1 1Department of Gastroenterology, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 2Research Center for Tissue Engineering and Regenerative Medicine, Union...

Full description

Saved in:
Bibliographic Details
Main Authors: Li G, Dai Z, Guo J
Format: Article
Language:English
Published: Dove Medical Press 2025-03-01
Series:International Journal of Nanomedicine
Subjects:
Online Access:https://www.dovepress.com/therapeutic-nanomaterials-in-nafld-current-advances-and-potential-appl-peer-reviewed-fulltext-article-IJN
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849393032339652608
author Li G
Dai Z
Guo J
author_facet Li G
Dai Z
Guo J
author_sort Li G
collection DOAJ
description Guixin Li,1,* Zheng Dai,2,3,* Jinghui Guo1 1Department of Gastroenterology, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 2Research Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People’s Republic of China; 3Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People’s Republic of China*These authors contributed equally to this workCorrespondence: Guixin Li; Jinghui Guo, Email lgxin0926@163.com; guohui19820623@126.comAbstract: Due to the high prevalence of non-alcoholic fatty liver disease (NAFLD) and chronic hepatitis B virus (HBV) infection, a significant proportion of patients suffer from both conditions simultaneously. The management of NAFLD in patients with concurrent HBV infection presents unique challenges, primarily due to the complex interplay between these two diseases. Nanomaterials have gained widespread attention due to their ability to overcome the limitations of conventional therapies. This review provides an overview of the current advances in therapeutic nanomaterials for NAFLD and explores their potential applications for personalized and effective management in patients with concurrent HBV infection. Furthermore, we discuss the challenges and future directions in the development of nanomaterials for the treatment of coexisting liver diseases.Keywords: nonalcoholic fatty liver disease, chronic hepatitis B virus infection, nanomaterials
format Article
id doaj-art-922c53de70f440e8abc0866ce68e4a21
institution Kabale University
issn 1178-2013
language English
publishDate 2025-03-01
publisher Dove Medical Press
record_format Article
series International Journal of Nanomedicine
spelling doaj-art-922c53de70f440e8abc0866ce68e4a212025-08-20T03:40:34ZengDove Medical PressInternational Journal of Nanomedicine1178-20132025-03-01Volume 2038033823101454Therapeutic Nanomaterials in NAFLD: Current Advances and Potential Applications in Patients with Concurrent HBV InfectionLi GDai ZGuo JGuixin Li,1,* Zheng Dai,2,3,* Jinghui Guo1 1Department of Gastroenterology, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 2Research Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People’s Republic of China; 3Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People’s Republic of China*These authors contributed equally to this workCorrespondence: Guixin Li; Jinghui Guo, Email lgxin0926@163.com; guohui19820623@126.comAbstract: Due to the high prevalence of non-alcoholic fatty liver disease (NAFLD) and chronic hepatitis B virus (HBV) infection, a significant proportion of patients suffer from both conditions simultaneously. The management of NAFLD in patients with concurrent HBV infection presents unique challenges, primarily due to the complex interplay between these two diseases. Nanomaterials have gained widespread attention due to their ability to overcome the limitations of conventional therapies. This review provides an overview of the current advances in therapeutic nanomaterials for NAFLD and explores their potential applications for personalized and effective management in patients with concurrent HBV infection. Furthermore, we discuss the challenges and future directions in the development of nanomaterials for the treatment of coexisting liver diseases.Keywords: nonalcoholic fatty liver disease, chronic hepatitis B virus infection, nanomaterialshttps://www.dovepress.com/therapeutic-nanomaterials-in-nafld-current-advances-and-potential-appl-peer-reviewed-fulltext-article-IJNnonalcoholic fatty liver diseasechronic hepatitis b virus infectionnanomaterials
spellingShingle Li G
Dai Z
Guo J
Therapeutic Nanomaterials in NAFLD: Current Advances and Potential Applications in Patients with Concurrent HBV Infection
International Journal of Nanomedicine
nonalcoholic fatty liver disease
chronic hepatitis b virus infection
nanomaterials
title Therapeutic Nanomaterials in NAFLD: Current Advances and Potential Applications in Patients with Concurrent HBV Infection
title_full Therapeutic Nanomaterials in NAFLD: Current Advances and Potential Applications in Patients with Concurrent HBV Infection
title_fullStr Therapeutic Nanomaterials in NAFLD: Current Advances and Potential Applications in Patients with Concurrent HBV Infection
title_full_unstemmed Therapeutic Nanomaterials in NAFLD: Current Advances and Potential Applications in Patients with Concurrent HBV Infection
title_short Therapeutic Nanomaterials in NAFLD: Current Advances and Potential Applications in Patients with Concurrent HBV Infection
title_sort therapeutic nanomaterials in nafld current advances and potential applications in patients with concurrent hbv infection
topic nonalcoholic fatty liver disease
chronic hepatitis b virus infection
nanomaterials
url https://www.dovepress.com/therapeutic-nanomaterials-in-nafld-current-advances-and-potential-appl-peer-reviewed-fulltext-article-IJN
work_keys_str_mv AT lig therapeuticnanomaterialsinnafldcurrentadvancesandpotentialapplicationsinpatientswithconcurrenthbvinfection
AT daiz therapeuticnanomaterialsinnafldcurrentadvancesandpotentialapplicationsinpatientswithconcurrenthbvinfection
AT guoj therapeuticnanomaterialsinnafldcurrentadvancesandpotentialapplicationsinpatientswithconcurrenthbvinfection